The following is provided for research and educational purposes only; the compounds and analytical methods described are intended for laboratory research use only and not for human or animal use.
A Certificate of Analysis (COA) is the primary document a laboratory uses to characterize a research compound before it enters an experiment. For researchers working with synthetic peptides, the COA is where identity, purity, and content are documented against the analytical methods that produced those numbers. Reading one well is a matter of knowing which assay reports which attribute, and what the acceptance criteria on each line actually describe. This guide walks through the four attributes researchers most often need to interpret — identity, purity, net peptide content, and appearance — and explains why independent, third-party testing is a meaningful signal of data quality.
What a COA documents
A COA is a batch-specific record. It is tied to a particular lot number and reports the results of the analytical tests run on material from that lot. Because peptide synthesis is a batch process, results are not transferable between lots: two vials of the same compound can carry different purity and content values if they came from different syntheses. When reading a COA, researchers generally confirm that the lot number on the certificate matches the lot on the vial, that a test date is present, and that each reported attribute is paired with the method used to measure it. A number without a named method — “99% pure” with no chromatogram or assay reference — is not verifiable.
Identity: confirmed by mass spectrometry
Identity answers a single question: is the molecule in the vial the peptide it claims to be? The standard method is mass spectrometry (MS), typically electrospray ionization (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI-TOF). The assay measures the molecular mass of the compound, which is then compared against the theoretical monoisotopic or average mass calculated from the peptide sequence.
On the COA, researchers look for the observed mass reported alongside the expected (theoretical) mass. A close match — usually within a fraction of a mass unit for the monoisotopic value, or the correct value for the most abundant charge state — supports the stated identity. Mass spectrometry confirms the molecular weight; it does not, on its own, prove purity, which is why it is read together with the chromatographic data below. A COA that reports only a purity percentage without any identity confirmation leaves the fundamental identity question unanswered.
Purity: the HPLC-UV main peak
Purity on a peptide COA is almost always determined by reversed-phase high-performance liquid chromatography with ultraviolet detection (RP-HPLC-UV). The sample is separated on a column, and compounds elute at different times. A UV detector records absorbance, producing a chromatogram of peaks. Purity is reported as the area of the main peak as a percentage of the total peak area — often written as “% by HPLC” or “area %”.
Several points help researchers interpret this figure accurately:
- It is a relative measurement. A 98% main peak means the target compound accounts for 98% of the total UV-absorbing area detected, with the remaining 2% attributable to related impurities such as truncated or deletion sequences.
- Detection wavelength matters. Peptides are commonly monitored at 214 nm (peptide bond absorbance) or 220 nm. Impurities that absorb weakly at the chosen wavelength may be under-represented, so the wavelength should be stated.
- A chromatogram is stronger evidence than a number. A COA that includes the actual HPLC trace lets a researcher see peak shape, baseline quality, and the size of neighboring peaks, rather than trusting a single reported value.
- Purity is not content. A high HPLC purity says the peptide fraction is clean; it does not say how much of the vial’s mass is peptide. That is a separate attribute.
Net peptide content
Net peptide content — sometimes called “peptide content” or “net peptide” — reports what fraction of the vial’s total mass is actually peptide. The remainder is typically bound water, residual counter-ions and salts (for example, trifluoroacetate from purification), and other non-peptide material. Content is commonly determined by amino acid analysis (AAA), or estimated by other quantitative methods, and reported as a percentage such as 80–90%.
This distinction is frequently misread. A vial can show 99% HPLC purity and 80% net peptide content at the same time: the peptide present is very clean, but only 80% of the labeled mass is peptide. For researchers performing quantitative work, net peptide content is the figure that governs how much active compound a given mass of powder represents. Laboratory reconstitution arithmetic — calculating concentration from mass and solvent volume — is more accurate when it accounts for net peptide content rather than assuming the full labeled mass is peptide. A reconstitution calculator can assist with this laboratory arithmetic.
Appearance
Appearance is the simplest line on the COA and the easiest to verify by eye. It records the physical description of the material — typically “white to off-white lyophilized powder” for a peptide. While it cannot confirm identity or purity, appearance is a first-pass check: discoloration, clumping in a compound expected to be a dry powder, or a physical form that does not match the certificate can indicate a handling, storage, or labeling problem worth investigating before any analytical work begins.
Why third-party testing matters
A COA is only as trustworthy as the laboratory that produced it. An in-house certificate carries an inherent conflict of interest: the party selling the material is also the party grading it. Independent, third-party analysis — testing performed by a laboratory with no stake in the result — removes that conflict and is a stronger signal of data integrity.
When evaluating who ran the tests, researchers often look for:
| Attribute | Method reported on COA | What it confirms |
|---|---|---|
| Identity | Mass spectrometry (ESI-MS / MALDI-TOF) | Molecular mass matches the target sequence |
| Purity | RP-HPLC-UV, main-peak area % | Fraction of the peptide portion that is the target compound |
| Net peptide content | Amino acid analysis / quantitative assay | Fraction of total vial mass that is peptide |
| Appearance | Visual inspection | Physical form matches the expected description |
Signals of a credible independent report include a named testing laboratory, a stated accreditation (such as ISO/IEC 17025 for testing competence), the analytical methods and instruments used, a lot number, a test date, and — ideally — the raw chromatograms and mass spectra rather than summary numbers alone. Luxe Peptides publishes lot-specific certificates in its COA library, where researchers can cross-check the lot on a vial against the documented identity, purity, and content data for that batch.
Putting it together
Read as a set, the four attributes answer complementary questions: mass spectrometry establishes what the compound is, HPLC-UV establishes how clean the peptide fraction is, net peptide content establishes how much of the mass is peptide, and appearance provides a physical cross-check. A complete, independently produced COA that reports a method and a result for each — and shows its work in the underlying chromatograms and spectra — is the documentation researchers rely on to characterize material before it enters an experiment.
References
- United States Pharmacopeia, General Chapter <621> Chromatography — standard framework for HPLC purity determination.
- United States Pharmacopeia, General Chapter <736> Mass Spectrometry — principles of mass measurement for identity confirmation.
- ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories — the accreditation standard commonly cited for independent analytical laboratories.
- Peer-reviewed methodological reviews on reversed-phase HPLC and mass spectrometric characterization of synthetic peptides (for example, in Journal of Chromatography A) describe the main-peak purity and identity workflows summarized here.
Research use only. The information and analytical methods described are for laboratory research and educational purposes and are not intended to diagnose, treat, or otherwise be used with humans or animals.